Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals to acquire Quill Medical
June 23rd, 2006
Angiotech Pharmaceuticals, Inc., (ANPI, ANP) has entered into a definitive agreement to acquire privately held Quill Medical, Inc., a provider of specialized, minimally invasive aesthetic surgery and wound closure technology, for US$40 million in cash, plus certain future contingent payments based on product revenues. Through this transaction, Angiotech will acquire all of Quill's technology and intellectual property, including the Contour Threads product line, which under its current license agreement is marketed and sold by Angiotech's Surgical Specialties division for use in aesthetic and cosmetic surgery. "This acquisition allows us to capitalize...
Source: Biotech Law Weekly (2006-06-23)
|
